Grail, Inc. (NASDAQ:GRAL - Get Free Report)'s share price rose 5.4% during trading on Wednesday . The company traded as high as $35.10 and last traded at $34.94. Approximately 238,647 shares changed hands during trading, a decline of 77% from the average daily volume of 1,049,903 shares. The stock had previously closed at $33.15.
Analyst Upgrades and Downgrades
Several research firms recently commented on GRAL. Wolfe Research initiated coverage on Grail in a research report on Friday, November 15th. They set a "peer perform" rating for the company. Morgan Stanley started coverage on shares of Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 target price on the stock.
Read Our Latest Stock Report on GRAL
Grail Price Performance
The company's 50-day moving average price is $23.94 and its 200-day moving average price is $18.11.
Insider Activity
In other Grail news, CFO Aaron Freidin sold 30,452 shares of the business's stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $14.02, for a total transaction of $426,937.04. Following the completion of the transaction, the chief financial officer now owns 268,277 shares in the company, valued at $3,761,243.54. The trade was a 10.19 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Crcm LP acquired a new position in shares of Grail in the 4th quarter valued at $65,061,000. Primecap Management Co. CA purchased a new position in Grail during the 4th quarter worth $37,118,000. Vanguard Group Inc. purchased a new position in shares of Grail in the 4th quarter valued at about $25,902,000. AQR Capital Management LLC purchased a new position in shares of Grail in the 4th quarter valued at about $14,828,000. Finally, Arbiter Partners Capital Management LLC purchased a new position in shares of Grail in the 4th quarter valued at about $14,827,000.
About Grail
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
See Also
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
